Winkler, R. (2015): Injectable bulking agents for faecal incontinence. Decision Support Document 87.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
Faecal incontinence (FI) is the involuntary loss of intestinal contents and causes both considerable physical impairments for patients and massive restrictions in the quality of life. Injectable bulking agents are a proposed alternative to conservative therapy options (e.g. dietary, sphincter training, biofeedback, medication). The aim of this systematic review was to evaluate the efficacy and safety of bulking agents in comparison to the standard therapy and to compare different bulking agents.
Seven controlled trials were identified within the context of the systematic literature search and hand search. The available (low) evidence suggests that patients with passive FI do not benefit more from bulking agents than from a standard therapy. Currently, the inclusion into the Austrian hospital benefit catalogue is not recommended. A re-evaluation is proposed for 2018.
|Item Type:||Decision Support Document|
|Keywords:||Faecal incontinence, bulking agents|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
WO Surgery > WO 500-517 Operative surgical procedures. Techniques
WI Digestive system > WI 600-650 Anus. Rectum
WO Surgery > WO 505 Minimally invasive surgical procedures
|Series Name:||Decision Support Document 87|
|Deposited on:||15 Jul 2015 13:48|
|Last Modified:||15 Jul 2015 13:48|
Repository Staff Only: item control page